Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | platelet-activating factor receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | g-protein coupled receptor | platelet-activating factor receptor | 342 aa | 302 aa | 22.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | dipeptidyl aminopeptidase 3, putative | 0.16 | 0.3664 | 0.2293 |
Toxoplasma gondii | cathepsin CPC2 | 0.16 | 0.3664 | 0.2293 |
Loa Loa (eye worm) | matrixin family protein | 0.0374 | 0.0695 | 0.6533 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.4217 | 1 | 1 |
Trypanosoma cruzi | Serine/threonine-protein kinase NEK16, putative | 0.0821 | 0.1779 | 1 |
Mycobacterium ulcerans | hydrolase | 0.0205 | 0.0287 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase Nek1 | 0.0801 | 0.1729 | 1 |
Schistosoma mansoni | matrix metallopeptidase-7 (M10 family) | 0.0244 | 0.0381 | 0.0381 |
Trypanosoma cruzi | Serine/threonine-protein kinase NEK11, putative | 0.0821 | 0.1779 | 1 |
Onchocerca volvulus | 0.0239 | 0.0369 | 0.2511 | |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.4217 | 1 | 1 |
Trypanosoma brucei | Serine/threonine-protein kinase NEK11, putative | 0.0821 | 0.1779 | 0.5 |
Brugia malayi | Matrix metalloprotease, N-terminal domain containing protein | 0.0205 | 0.0287 | 0.1169 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.4217 | 1 | 1 |
Toxoplasma gondii | cathepsin CPC1 | 0.4217 | 1 | 1 |
Trypanosoma cruzi | NIMA-related kinase, putative | 0.0821 | 0.1779 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0239 | 0.0369 | 0.0369 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.4217 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0821 | 0.1779 | 0.1779 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.4217 | 1 | 1 |
Onchocerca volvulus | Matrilysin homolog | 0.0449 | 0.0878 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.4217 | 1 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 3 | 0.16 | 0.3664 | 0.2293 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.16 | 0.3664 | 0.2293 |
Loa Loa (eye worm) | hypothetical protein | 0.0244 | 0.0381 | 0.2395 |
Leishmania major | protein kinase, putative,serine/threonine-protein kinase Nek1, putative | 0.0821 | 0.1779 | 0.5 |
Echinococcus multilocularis | serine:threonine protein kinase Nek1 | 0.0801 | 0.1729 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 0.0287 | 0.1169 |
Brugia malayi | Hemopexin family protein | 0.0239 | 0.0369 | 0.2241 |
Brugia malayi | Matrixin family protein | 0.0483 | 0.0959 | 1 |
Mycobacterium leprae | PROBABLE HYDROLASE | 0.0205 | 0.0287 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.2617 | 0.6126 | 1 |
Mycobacterium tuberculosis | Probable peptidoglycan hydrolase | 0.0205 | 0.0287 | 0.5 |
Trypanosoma cruzi | Serine/threonine-protein kinase NEK11, putative | 0.0821 | 0.1779 | 1 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0374 | 0.0695 | 0.7317 |
Giardia lamblia | Encystation-specific protease | 0.16 | 0.3664 | 0.2293 |
Trypanosoma brucei | NIMA-related protein kinase | 0.0821 | 0.1779 | 0.5 |
Trypanosoma brucei | Serine/threonine-protein kinase NEK16, putative | 0.0821 | 0.1779 | 0.5 |
Loa Loa (eye worm) | matrixin family protein | 0.0483 | 0.0959 | 1 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0821 | 0.1779 | 0.5 |
Giardia lamblia | Dipeptidyl-peptidase I precursor | 0.16 | 0.3664 | 0.2293 |
Leishmania major | serine/threonine-protein kinase, putative | 0.0821 | 0.1779 | 0.5 |
Leishmania major | protein kinase, putative | 0.0821 | 0.1779 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 60 nM | Inhibitory effect on PAF induced platelets aggregation in rabbit | ChEMBL. | No reference |
IC50 (functional) | = 60 nM | Inhibitory effect on PAF induced platelets aggregation in rabbit | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.